Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NeuroRx

NeuroRx
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$18.3M LATEST DEAL AMOUNT
Description

Developer of novel therapeutics intended to be used for the treatment of central nervous system disorders. The company's therapeutics offers sequential drug treatment regimen for Bipolar Depression in patients with Acute Suicidal Ideation & Behavior (ASIB), enabling healthcare practitioners to offer advanced and effective treatment to BPD patients.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 913 North Market Street
  • Suite 200
  • Wilmington, DE 19801
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NeuroRx’s full profile, request a free trial.

NeuroRx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Dec-2018 $18.3M 0000 00000 Completed Startup
1. Angel (individual) 21-Nov-2016 00.00 00.00 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

NeuroRx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B-1A 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series B-1 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A 1,000,000 $0.001000 $1 $1 1x $1 8.04%
To view this company’s complete Cap Table, request access »

NeuroRx Executive Team (7)

Name Title Board
Seat
Contact
Info
Jonathan Javitt MD Co-Founder, Board Member & Chief Executive Officer
James Brandon Comptroller & Acting Chief Financial Officer
Dennis McBride Ph.D Chief Strategy Officer & Senior Scientist
Richard Siegel Ph.D Chief Scientific Officer & Executive Vice President of Drug Development and Manufacture
Robert Besthof Chief Commercial & Patient Officer
You’re viewing 5 of 7 executives. Get the full list »

NeuroRx Board Members (6)

Name Representing Role Since Contact
Info
Aaron Gorovitz Self Board Member 000 0000
Chaim Hurvitz Self Board Member 000 0000
Daniel Javitt Ph.D NeuroRx Co-Founder, Scientific Advisory Board Member & Chairman 000 0000
James Lawrence NeuroRx Board Member 000 0000
Patrick Flynn Self Board Member & Audit Committee Chairman 000 0000
You’re viewing 5 of 6 board members. Get the full list »